Table 2. Literature review of lacrimal gland ACC.
Study (Year) | # of patients studied with ACC of lacrimal gland | Gender | Mean age at diagnosis, years (range) | # of patients alive without disease after treatment | Median follow-up, years (range) | Mean survival time |
---|---|---|---|---|---|---|
Font et al12 | 13 | 9M, 4F | 44 (14–80) | 2 | 8.5 Years (1–16 years) | 4.5 Years from time of initial surgery |
Perez et al14 | 12 | 6M, 6F | 40.4 (19–52) | 4 | N/A | 77.8 Months from time of completion of treatment |
Esmaeli et al4 | 20 | 6M, 14F | 39.5 (10–68) | 6 | 34 Months (6–264 months) | 18 Months from time of completion of treatment |
Williams et al13 | 18 | 8M, 10F | 43 (9–69) | 10 | 26.5 Months (6–102 months) | N/A |
von Holstein et al3 | 14 | 7M, 7F | 43 (23–67) | 5 | 7 Years (1–27 years) | Median tumor-specific survival was 8.6 years |